Entresto Risky for Advanced Heart Failure?

(MedPage Today) -- Sacubitril/valsartan (Entresto) didn't appear to help patients with advanced heart failure in the LIFE trial when compared with an angiotensin receptor blocker alone.
The combination agent failed to improve N-terminal pro-B...